You have access
Efficacy of Sunitinib in Patients With Favorable and Intermediate Risk Metastatic Renal Cell Carcinoma – Lithuanian National Cancer Institute Experience
ALGIRDAS ZALIMAS, VINCAS URBONAS, DAIVA DABKEVICIENE, JONAS PURVANECKAS, ALBERTAS ULYS and SONATA JARMALAITE
Anticancer Research January 2024, 44 (1) 213-219; DOI: https://doi.org/10.21873/anticanres.16804